False positive result of human chorionic gonadotropin caused by human anti-mouse antibodies

Immunochemical reactions are fast, can be automated, and generally do not require pretreatment of biological material. Based on these advantages, they are widely used. On the other hand, they are susceptible to analytical interference that can lead to inaccurate results. These factors include the presence of anti-mouse antibodies, causing false positive (or sometimes false negative) results. Although the anti-mouse antibodies over many decades have been repeatedly identified to be the causative source but due to the rarity of such encounters they remain insufficiently considered. Here we show a case, a 45 year-old female who was mis-diagnosed with pregnancy due to falsely elevated human chorionic gonadotropin (hCG) due to anti-mouse antibodies. This led to the patient undergoing two ultrasound examinations and laparoscopy before the hCG was repeated on alternative assays which showed negative results, preventing the patient from methotrexate treatment. Here we describe the details of the case, outline the assay principal, supporting the finding from literature and outlining a process on how to identify such interferences in timely manner.

[1]  J. Rácek,et al.  Persistence of High Serum Digoxin Concentrations. , 2021, Clinical chemistry.

[2]  D. Schust,et al.  A rational diagnostic approach to the “phantom hCG” and other clinical scenarios in which a patient is thought to be pregnant but is not , 2021, Therapeutic advances in reproductive health.

[3]  B. Basok.  Understanding and managing biotin interference in immunoassays , 2020 .

[4]  M. Kelner,et al.  A Dilution Method to Mitigate Biotin Interference in Cardiac Troponin T Testing. , 2019, The journal of applied laboratory medicine.

[5]  S. Brennan,et al.  Deciphering a macro-troponin I complex; a case report , 2017, Clinical chemistry and laboratory medicine.

[6]  J. Warner,et al.  High incidence of macrotroponin I with a high-sensitivity troponin I assay , 2016, Clinical chemistry and laboratory medicine.

[7]  O. Eroğlu,et al.  False Positive Test or Phantom hCG: A Case Report , 2016 .

[8]  M. Pudek,et al.  Macrotroponin causing elevation in cardiac troponin I. , 2014, The Canadian journal of cardiology.

[9]  Rajesh C. Dash,et al.  State of the Art in Clinical and Anatomic Pathology , 2012 .

[10]  M. Blankenstein,et al.  Interference in human chorionic gonadotropin (hCG) analysis by macro-hCG. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[11]  M. Janssen,et al.  False positive troponin result caused by a true macrotroponin , 2011, Clinical chemistry and laboratory medicine.

[12]  A. Zaidi,et al.  False positive cardiac troponin elevation due to heterophile antibodies: more common than we recognise? , 2010, BMJ Case Reports.

[13]  Horng‐Jyh Tsai.  Phantom HCG and clinical management. , 2006, Taiwanese journal of obstetrics & gynecology.

[14]  J. Gibney,et al.  Specificity and clinical utility of methods for the detection of macroprolactin. , 2004, Clinical chemistry.

[15]  A. Dasgupta.  Therapeutic Drug Monitoring of Digoxin , 2006, Toxicological reviews.

[16]  L. Cole,et al.  Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results. , 2005, Obstetrics and gynecology clinics of North America.

[17]  J. Goldberg,et al.  Heterophile Antibody Blocking Agent to Confirm False Positive Serum Human Chorionic Gonadotropin Assay , 2003, Obstetrics and gynecology.

[18]  Gynecologists.  ACOG. Committee opinion: number 278, November 2002. Avoiding inappropriate clinical decisions based on false-positive human chorionic gonadotropin test results. , 2002, Obstetrics and gynecology.

[19]  F. Apple,et al.  False-positive AxSYM cardiac troponin I results in a 53-year-old woman. , 2002, Archives of pathology & laboratory medicine.

[20]  L. Cole,et al.  Use of heterophilic antibody blocking agent (HBT) in reducing false-positive hCG results. , 2001, Clinical chemistry.

[21]  A. Dasgupta,et al.  Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations. , 2001, American journal of clinical pathology.

[22]  L J Kricka,et al.  Human anti-animal antibody interferences in immunological assays. , 1999, Clinical chemistry.

[23]  D. Bruns,et al.  University of Virginia case conference. Macroamylase, macro creatine kinase, and other macroenzymes. , 1985, Clinical chemistry.